Send to

Choose Destination
J Biochem Biophys Methods. 2002 Dec 31;54(1-3):415-22.

Enantiomeric resolution of a novel chiral cannabinoid receptor ligand.

Author information

Department of Pharmaceutical Sciences and the Center for Drug Discovery, University of Connecticut, 372 Fairfield Road, Storrs, CT 06269, USA.


The enantiomeric resolution of a racemic novel cannabinoid receptor ligand conformationally restricted at the southern aliphatic chain was accomplished using a ChiralPak AD column. Both enantiomers were tested for their competitive binding to the rat brain CB1, mouse spleen CB2 and human CB2 receptors. The levorotatory isomer showed exceptionally high affinity for the CB1 receptor with a seven-fold selectivity over CB2.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center